CA Patent

CA2534660A1 — Single unit pharmaceutical composition comprising a mixture of a fibrate and an homocysteine reducing agent

Assigned to Galephar MF · Expires 2005-02-10 · 21y expired

What this patent protects

An oral lipid lowering pharmaceutical unit form comprising a first solid or semi solid composition comprising fenofibrate and a second solid or semi solid composition comprising at least a modified release form of an homocysteine lowering agent.

USPTO Abstract

An oral lipid lowering pharmaceutical unit form comprising a first solid or semi solid composition comprising fenofibrate and a second solid or semi solid composition comprising at least a modified release form of an homocysteine lowering agent.

Drugs covered by this patent

Patent Metadata

Patent number
CA2534660A1
Jurisdiction
CA
Classification
—
Expires
2005-02-10
Drug substance claim
No
Drug product claim
No
Assignee
Galephar MF
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.